PT Itama Ranoraya Tbk's quarterly market cap
declined
from Sep. 2025 (Rp660,424 Mil) to Dec. 2025 (Rp639,314 Mil) and
declined
from Dec. 2025 (Rp639,314 Mil) to Mar. 2026 (Rp579,002 Mil).
PT Itama Ranoraya Tbk's annual market cap
declined
from Dec. 2023 (Rp1,206,254 Mil) to Dec. 2024 (Rp603,127 Mil) but then
increased
from Dec. 2024 (Rp603,127 Mil) to Dec. 2025 (Rp639,314 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. PT Itama Ranoraya Tbk's Enterprise Value for Today is Rp1,439,542 Mil.
PT Itama Ranoraya Tbk (ISX:IRRA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, PT Itama Ranoraya Tbk's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Itama Ranoraya Tbk Market Cap vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Itama Ranoraya Tbk's Market Cap distribution charts can be found below:
* The bar in red indicates where PT Itama Ranoraya Tbk's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
PT Itama Ranoraya Tbk's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Itama Ranoraya Tbk (ISX:IRRA) has a Market Cap of Rp563,924 Mil as of Jul. 03, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PT Itama Ranoraya Tbk and its competitors. According to the industry distribution chart, PT Itama Ranoraya Tbk ranks #90 out of 120 companies in the Medical Distribution industry, placing it in the top 75%.
Is PT Itama Ranoraya Tbk's Market Cap too high?
PT Itama Ranoraya Tbk's current Market Cap is Rp563,924 Mil. Based on the distribution chart, PT Itama Ranoraya Tbk ranks #90 out of 120 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, PT Itama Ranoraya Tbk has a GF Score™ of 81/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PT Itama Ranoraya Tbk's Market Cap compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, PT Itama Ranoraya Tbk ranks #90 out of 120 companies for Market Cap. This places PT Itama Ranoraya Tbk in the lower half of its industry. The industry median Market Cap is 146.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Distribution company?
The median Market Cap among Medical Distribution companies is 146.50, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PT Itama Ranoraya Tbk and its competitors. For the Medical Distribution industry, the median Market Cap is 146.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Itama Ranoraya Tbk's current Market Cap is Rp563,924 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Itama Ranoraya Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Itama Ranoraya Tbk (ISX:IRRA) is currently considered Possible Value Trap. The stock's GF Value™ is Rp535.49, compared to a current price of Rp374.00 — trading 30.2% below its estimated fair value. The current Market Cap is Rp563,924 Mil. PT Itama Ranoraya Tbk's overall GF Score™ is 81/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For PT Itama Ranoraya Tbk (ISX:IRRA), the current Market Cap is Rp563,924 Mil as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Itama Ranoraya Tbk (ISX:IRRA) Overvalued in 2026?
Based on GuruFocus' analysis, PT Itama Ranoraya Tbk stock appears to be undervalued.
The current stock price of Rp374.00 is trading 30.2% below its estimated GF Value™ of Rp535.49.
GuruFocus considers PT Itama Ranoraya Tbk to be Possible Value Trap.
Key valuation signals for ISX:IRRA:
Market Cap: Rp563,924 Mil
GF Value™: Rp535.49 vs. price of Rp374.00 (30.2% below fair value)
No single metric tells the full story. See the ISX:IRRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Itama Ranoraya Tbk focuses on the trade and distribution of medical devices. The company distributes medical devices such as Oneject auto disable syringe, Abbott diagnostics, TerumoBCT, Ortho Clinical diagnostics and others. It business segment includes Vitro Diagnostic Products, Non-Electromedical Sterile Medical Devices, Electromedical Sterile Medical Devices and Other Segments. The key revenue generating segments of the company are In Vitro Diagnostic product.
81GF Score
Get the complete analysis for ISX:IRRA
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:IRRA has been successfully added to your 
